Cargando…

Non-neutralizing antibodies: Deleterious or propitious during SARS-CoV-2 infection?

Antibody-dependent enhancement (ADE) is a complex phenomenon mediated by antibodies, frequently pre-existing non-neutralizing or sub-neutralizing antibodies. In the course of infectious diseases, ADE may be responsible for worsening the clinical course of the disease by increasing the virulence of p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zanella, Isabella, Degli Antoni, Melania, Marchese, Valentina, Castelli, Francesco, Quiros-Roldan, Eugenia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189100/ https://www.ncbi.nlm.nih.gov/pubmed/35753123 http://dx.doi.org/10.1016/j.intimp.2022.108943

Ejemplares similares

Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives
por: Quiros-Roldan, Eugenia, et al.
Publicado: (2021)

An HIV elite controller patient carrying the homozygous H63D variant in the homeostatic iron regulator gene: A case report
por: Zanella, Isabella, et al.
Publicado: (2021)

Cabotegravir Exposure of Zebrafish (Danio rerio) Embryos Impacts on Neurodevelopment and Behavior
por: Zizioli, Daniela, et al.
Publicado: (2023)

Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review
por: Tiecco, Giorgio, et al.
Publicado: (2022)

Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection
por: Zanella, Isabella, et al.
Publicado: (2021)

Correction: Zanella et al. Tenofovir, Another Inexpensive, Well Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection. Pharmaceuticals 2021, 14, 454
por: Zanella, Isabella, et al.
Publicado: (2021)

A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines
por: Tiecco, Giorgio, et al.
Publicado: (2021)

Explorative study regarding influenza vaccine hesitancy among HIV-infected patients
por: Marchese, Valentina, et al.
Publicado: (2022)

An exploratory pilot study on the involvement of APOE, HFE, C9ORF72 variants and comorbidities in neurocognitive and physical performance in a group of HIV-infected people
por: Zanella, Isabella, et al.
Publicado: (2022)

Monkeypox, a Literature Review: What Is New and Where Does This concerning Virus Come From?
por: Tiecco, Giorgio, et al.
Publicado: (2022)

Syphilis Infections, Reinfections and Serological Response in a Large Italian Sexually Transmitted Disease Centre: A Monocentric Retrospective Study
por: Marchese, Valentina, et al.
Publicado: (2022)

Omicron BA.2 Lineage, the “Stealth” Variant: Is It Truly a Silent Epidemic? A Literature Review
por: Tiecco, Giorgio, et al.
Publicado: (2022)

The impact of early therapies for COVID-19 on death, hospitalization and persisting symptoms: a retrospective study
por: Bertuccio, Paola, et al.
Publicado: (2023)

Letter to the Editor on “Bonafè M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev”
por: Quiros-Roldan, Eugenia, et al.
Publicado: (2020)

Epistasis at the SARS-CoV-2 RBD Interface and the Propitiously Boring Implications for Vaccine Escape
por: Rochman, Nash D., et al.
Publicado: (2021)

The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
por: Quiros Roldan, Eugenia, et al.
Publicado: (2020)

Lopinavir/ritonavir: Repurposing an old drug for HIV infection in COVID-19 treatment
por: Magro, Paola, et al.
Publicado: (2021)

Decrease in new diagnosis of HIV/AIDS in the two years period 2019-2020: Impact of COVID-19 pandemic
por: Quiros-Roldan, Eugenia, et al.
Publicado: (2021)

Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape
por: Rochman, Nash D., et al.
Publicado: (2022)

The importance of SHBG and calculated free testosterone for the diagnosis of symptomatic hypogonadism in HIV-infected men: a single-centre real-life experience
por: Pezzaioli, Letizia Chiara, et al.
Publicado: (2020)

The impact of antiretroviral therapy on iron homeostasis and inflammation markers in HIV-infected patients with mild anemia
por: Quiros-Roldan, Eugenia, et al.
Publicado: (2017)

SARS-CoV-2 Infection and Vaccination Coverage among Fragile Populations in a Local Health Area of Northern Italy
por: Maifredi, Giovanni, et al.
Publicado: (2022)

Real-life use of Doravirine in treatment-experienced people living with HIV: A multicenter Italian study
por: Mazzitelli, Maria, et al.
Publicado: (2022)

Lineup fairness: propitious heterogeneity and the diagnostic feature-detection hypothesis
por: Carlson, Curt A., et al.
Publicado: (2019)

The Rise of Predatory Journals in Foot and Ankle Surgery: Propitious or Detrimental?
por: Adeyemo, Adeshina, et al.
Publicado: (2020)

Comparison of Efavirenz and Doravirine Developmental Toxicity in an Embryo Animal Model
por: Zizioli, Daniela, et al.
Publicado: (2023)

Fusarium verticillioides of maize plant: Potentials of propitious phytomicrobiome as biocontrol agents
por: Omotayo, Oluwadara Pelumi, et al.
Publicado: (2023)

Nigelladine A among Selected Compounds from Nigella sativa Exhibits Propitious Interaction with Omicron Variant of SARS-CoV-2: An In Silico Study
por: Miraz, Md Mehedy Hasan, et al.
Publicado: (2023)

Efficacy of Single-Channel EEG: A Propitious Approach for In-home Sleep Monitoring
por: Radhakrishnan, B. L., et al.
Publicado: (2022)

Immunological Evolution of a Cohort of HIV-2 Infected Patients: Peculiarities of an Underestimated Infection
por: Fumarola, Benedetta, et al.
Publicado: (2022)

Timing and implications for immune response to vaccine in SARS-CoV-2 breakthrough infections
por: Arsuffi, Stefania, et al.
Publicado: (2023)

Solanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidate
por: Sharma, Divya, et al.
Publicado: (2023)

Characteristics of the population with mild COVID-19 symptoms eligible for early treatment attended in a single center in Northern Italy
por: Magro, Paola, et al.
Publicado: (2023)

COVID-19 Pneumonia with Migratory Pattern in Agammaglobulinemic Patients: A Report of Two Cases and Review of Literature
por: Degli Antoni, Melania, et al.
Publicado: (2023)

Antibody-mediated neutralization of SARS-CoV-2
por: Gruell, Henning, et al.
Publicado: (2022)

Neutralizing antibodies for SARS-CoV-2 infection
por: Berenguer, Juan
Publicado: (2022)

High frequency of type I interferon auto‐antibodies in a group of middle‐aged HIV‐infected patients: A cross‐sectional exploratory study
por: Imberti, Luisa, et al.
Publicado: (2023)

Antiviral Peptides (AVPs) of Marine Origin as Propitious Therapeutic Drug Candidates for the Treatment of Human Viruses
por: Sukmarini, Linda
Publicado: (2022)

Evidence for deleterious effects of immunological history in SARS-CoV-2
por: Sen, Sanjana R., et al.
Publicado: (2022)

Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia
por: Marchese, Valentina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_un5crpjdi0rqgqhhhpumd6f4k5